Miguel-Ángel Barba-Romero
Albacete University Hospital Complex, Spain
Dr. M.A. Barba Romero graduated in Medicine and Surgery from the Complutense University of Madrid in 1987 and received his Ph.D. from the Autonomous University of Madrid in 2014 with an extraordinary doctoral award. After completing his residency in Internal Medicine at the Albacete University Hospital Complex, he has been working at that centre since 1994. Since 2003, he has served as an assistant professor (Semeiotics and Propaedeutics) at the Faculty of Medicine of Albacete at the University of Castilla-La Mancha. Since 1994, he has been responsible for the follow-up of patients with lysosomal storage disorders, and in recent years he has collaborated with the Paediatrics Department on the transition of patients with inborn errors of metabolism. He is a member of the Rare Diseases Group and the Cardiovascular Risk Group of the Spanish Society of Internal Medicine (SEMI). Likewise, he is a member of AECOM (the Spanish Association for the Study of Inborn Errors of Metabolism). He has participated in several clinical trials related to dyslipidaemias (Phase 3 and Phase 4) and collaborates on the cohort follow-up project for patients with familial hypercholesterolemia in Spain (SAFEHEART). He has participated in the Fabry Outcome Survey (FOS) and currently actively participates in the Spanish Pompe Disease Registry (GENRARE-CIBERER) and the international registry of patients with lysosomal acid lipase deficiency. He has published various articles in scientific journals and book chapters, and has delivered communications, lectures, and moderated sessions at national and international congresses, primarily concerning dyslipidaemias and lysosomal storage disorders.
